Graf Akcie BGNE (BeiGene Ltd). Diskuze k akciím BGNE. Aktuální informace BGNE.

Základní informace o společnosti BeiGene Ltd (Akcie BGNE)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 34.19B
Hodnota podniku (EV) 32.39B
Tržby 947.044M
EBITDA -1.33
Zisk -1.31
Růst v tržbách Q/Q 128.52 %
Růst v tržbách Y/Y 321.42 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 34.21
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 36.10
P/FCF N/A
Price/Book 8.84
Účetní hodnota na akcii 41.10
Hotovost na akcii 49.41
FCF vůči ceně -3.27 %
Počet zaměstnanců 5,300
Tržba na zaměstnance 178.688k
Profit margin -517.01 %
Operating margin -140.41 %
Gross margin 77.12 %
EBIT margin -139.34 %
EBITDA margin -140.33 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -114.68 %
EPS - Očekávaný růst příští rok 19.26 %
Return on assets -23.31 %
Return on equity -33.28 %
ROIC -44.92 %
ROCE -30.82 %
Dluhy/Equity 0.45
Čistý dluh/EBITDA 12.37
Current ratio 3.86
Quick Ratio 3.77
Volatilita 4.28
Beta 0.67
RSI 54.27
Cílová cena analytiků 298
Známka akcie (dle analytiků) 1.94
Insider ownership 20.36 %
Institutional ownership 62.62 %
Počet akcií 93.038M
Procento shortovaných akcií 0.00 %
Short ratio 6.20 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2016
Země China

Finanční výsledky akcie BGNE

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$428.212$198.22$238.387$1.07$8.816$13.035$11.148
Cost Of Goods Sold$71.19$28.705$4.974----
Gross Profit$357.022$169.515$233.413$1.07$8.816$13.035$11.148
Research And Development Expenses$927.338$679.005$269.018$98.033$58.25$21.862$13.463
SG&A Expenses$388.249$195.385$62.602$20.097$7.311$6.93$3.143
Other Operating Income Or Expenses-------
Operating Expenses$1,388.103$903.989$336.844$118.13$65.561$28.792$16.606
Operating Income$-959.891$-705.769$-98.457$-117.06$-56.745$-15.757$-5.458
Total Non-Operating Income/Expense$16.305$15.94$7.393$-2.103$-0.357$-2.789$-2.436
Pre-Tax Income$-943.586$-689.829$-91.064$-119.163$-57.102$-18.546$-7.894
Income Taxes$6.992$-15.796$2.235$0.054---
Income After Taxes$-950.578$-674.033$-93.299$-119.217$-57.102$-18.546$-7.894
Other Income-------
Income From Continuous Operations$-950.578$-674.033$-93.299$-119.217$-57.102$-18.546$-7.894
Income From Discontinued Operations-------
Net Income$-948.628$-673.769$-93.105$-119.217$-57.102$-18.278$-7.494
EBITDA$-941.274$-695.381$-93.699$-115.151$-55.2$-14.2$-3.866
EBIT$-959.891$-705.769$-98.457$-117.06$-56.745$-15.757$-5.458
Basic Shares Outstanding60554231987
Shares Outstanding60554231987
Basic EPS$-15.80$-12.15$-2.23$-3.84$-6.71$-2.38$-1.04
EPS - Earnings Per Share$-15.80$-12.15$-2.23$-3.84$-6.71$-2.38$-1.04
# 2020 2019 2018 2017 2016 2015
Current Ratio3.77917.88736.090510.67943.02143.5291
Long-term Debt / Capital0.19740.09760.18520.04670.0769-0.342
Debt/Equity Ratio0.2460.11310.24070.0490.2797-0.2609
Gross Margin83.375185.518697.9135100100100
Operating Margin-224.1626-356.0534-41.3013-10940.19-643.6592-120.8822
EBIT Margin-224.1626-356.0534-41.3013-10940.19-643.6592-120.8822
EBITDA Margin-219.8149-350.8127-39.3054-10761.78-626.1343-108.9375
Pre-Tax Profit Margin-220.3549-348.0118-38.2001-11136.73-647.7087-142.2785
Net Profit Margin-221.5323-339.9097-39.0562-11141.78-647.7087-140.2225
Asset Turnover0.26560.08810.22780.00260.07550.2431
Inventory Turnover Ratio2.49331.76730.4551---
Receiveable Turnover6.04154.8288.1007---
Days Sales In Receivables60.415175.645.0579---
ROE - Return On Equity-97.1608-38.4361-13.6356-33.781456.111634.9654
Return On Tangible Equity-97.7449-39.616-14.0425-33.7814-76.833734.9654
ROA - Return On Assets-58.9583-29.9612-8.9155-29.3773-48.9038-34.5872
ROI - Return On Investment-77.977-34.6846-11.1107-32.2042-70.92846.9222
Book Value Per Share15.871629.367915.02358.89388.3159-6.3553
Operating Cash Flow Per Share-2.6143-10.18413.18831.8002-3.5514-1.7107
Free Cash Flow Per Share-2.148-11.03272.83521.6679-4.0908-1.7603

Porovnání s konkurencí: Akcie BGNE

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BGNE N/A N/A 321.42 % 19.26 % -33.28 % 8.84 -517.01 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 10.05 -894.31 %

Nedávné obchody insiderů: Akcie BGNE

Jméno Obchod Cena Objem
Xiaobin Wu
President and GM China
Prodej
5 Oct 2020
$300.00 $1,200,000
Xiaodong Wang
Director
Prodej
5 Oct 2020
$300.00 $1,500,000
Xiaodong Wang
Director
Prodej
16 Oct 2020
$320.00 $1,600,000
Jane Huang
CMO and Hematology
Option
29 Oct 2020
$29.49 $44,235
Jane Huang
CMO and Hematology
Option
30 Nov 2020
$29.49 $44,235
Bros. Advisors Lp667, L.P.B...
Prodej
4 Dec 2020
$220.50 $333,295,893
Howard Liang
CFO and Chief Strategy Officer
Option
14 Dec 2020
$0.87 $1,302,564
Jane Huang
CMO and Hematology
Option
29 Dec 2020
$29.49 $44,235
Bros. Advisors Lp667, L.P.B...
Prodej
4 Jan 2021
$220.50 $26,714,457
Howard Liang
CFO and Chief Strategy Officer
Option
14 Jan 2021
$6.50 $91,000
Jane Huang
CMO and Hematology
Option
29 Jan 2021
$29.49 $44,235

Diskuze k akciím BGNE